112 related articles for article (PubMed ID: 1474279)
21. [New WHO recommendations for the treatment of leprosy].
Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
[No Abstract] [Full Text] [Related]
22. Study of 39 documented relapses of multibacillary leprosy after treatment with rifampin.
Grosset JH; Guelpa-Lauras CC; Bobin P; Brucker G; Cartel JL; Constant-Desportes M; Flageul B; Frédéric M; Guillaume JC; Millan J
Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):607-14. PubMed ID: 2674301
[TBL] [Abstract][Full Text] [Related]
23. Activity of two doses of rifampin against Mycobacterium leprae.
Husser JA; Traore I; Daumerie D
Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):359-64. PubMed ID: 7963907
[TBL] [Abstract][Full Text] [Related]
24. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
Mane I; Cartel JL; Grosset JH
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
[TBL] [Abstract][Full Text] [Related]
25. Ofloxacin containing combined drug regimens in the treatment of multibacillary leprosy.
Sampoonachot P; Bundit C; Kuhacharoen N; Peerapakorn S; Kampirapap K; Poomlek A; Bampenyu S; Tiasiri S; Rungruang S; Surasondhi S; Supanwanit S; Wiriyawipart S
Southeast Asian J Trop Med Public Health; 1997 Dec; 28(4):803-10. PubMed ID: 9656405
[TBL] [Abstract][Full Text] [Related]
26. Studies on therapeutic activity of benzoxazinorifamycin KRM-1648 in combination with other antimicrobial agents and biological response modifiers interferon-gamma and granulocyte-macrophage colony-stimulating factor against M. leprae infection in athymic nude mice.
Maw WW; Tomioka H; Sato K; Saito H
Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):345-51. PubMed ID: 9401487
[TBL] [Abstract][Full Text] [Related]
27. In vitro and in vivo activities of ofloxacin against Mycobacterium leprae infection induced in mice.
Saito H; Tomioka H; Nagashima K
Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):560-2. PubMed ID: 3546546
[TBL] [Abstract][Full Text] [Related]
28. Further studies of the killing of M. leprae by aminoglycosides: reduced dosage and frequency of administration.
Gelber RH
Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):78-82. PubMed ID: 3549941
[TBL] [Abstract][Full Text] [Related]
29. Ofloxacin for the treatment of leprosy.
Ji B; Grosset J
Acta Leprol; 1991; 7(4):321-6. PubMed ID: 1950440
[TBL] [Abstract][Full Text] [Related]
30. Combination of rifapentine-moxifloxacin-minocycline (PMM) for the treatment of leprosy.
Ji B; Grosset J
Lepr Rev; 2000 Dec; 71 Suppl():S81-7. PubMed ID: 11201894
[TBL] [Abstract][Full Text] [Related]
31. Activity of sparfloxacin against Mycobacterium leprae measured by the proportional bactericidal test.
McDermott-Lancaster RD; Banerjee DK
Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):605-8. PubMed ID: 8151193
[TBL] [Abstract][Full Text] [Related]
32. Activity of the combination of isoniazid, protionamide and dapsone against Mycobacterium leprae and some other mycobacteria.
Pattyn SR; Portaels F; Van Loo G; Van den Breen L
Arzneimittelforschung; 1981; 31(12):2155-7. PubMed ID: 7037011
[TBL] [Abstract][Full Text] [Related]
33. High relapse rate among lepromatous leprosy patients treated with rifampin plus ofloxacin daily for 4 weeks.
Ji B; Jamet P; Sow S; Perani EG; Traore I; Grosset JH
Antimicrob Agents Chemother; 1997 Sep; 41(9):1953-6. PubMed ID: 9303392
[TBL] [Abstract][Full Text] [Related]
34. Antagonism between dapsone and rifampicin in experimental Mycobacterium leprae infections in mice.
Millan JP; Moulia-Pelat JP
Res Microbiol; 1989 Feb; 140(2):143-50. PubMed ID: 2678328
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic efficacy of benzoxazinorifamycin, KRM-1648, in combination with other antimicrobials against Mycobacterium leprae infection induced in nude mice.
Saito H; Tomioka H; Sato K; Dekio S
Int J Lepr Other Mycobact Dis; 1994 Mar; 62(1):43-7. PubMed ID: 8189088
[TBL] [Abstract][Full Text] [Related]
36. The activity of several newer antimicrobials against logarithmically multiplying M. leprae in mice.
Burgos J; de la Cruz E; Paredes R; Andaya CR; Gelber RH
Lepr Rev; 2011 Sep; 82(3):253-8. PubMed ID: 22125933
[TBL] [Abstract][Full Text] [Related]
37. [Research in the campaign against leprosy (author's transl)].
Freerksen E
MMW Munch Med Wochenschr; 1977 Sep; 119(35):1115-8. PubMed ID: 408667
[TBL] [Abstract][Full Text] [Related]
38. Screening of drugs for activity against Mycobacterium leprae.
Baohong J; Matsuo Y; Colston MJ
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):836-42. PubMed ID: 3325576
[No Abstract] [Full Text] [Related]
39. Effect of treatment on PCR positivity in multibacillary leprosy patients treated with conventional and newer drugs ofloxacin and minocycline.
Singh HB; Katoch K; Natrajan M; Sharma RK; Gupta UD; Sharma VD; Singh D; Chauhan DS; Srivastava K; Katoch VM
Acta Leprol; 1999; 11(4):179-82. PubMed ID: 10987049
[TBL] [Abstract][Full Text] [Related]
40. Bacterial growth kinetics of "M. lufu" in the presence and absence of various drugs alone and in combination. A model for the development of combined chemotherapy against M. leprae?
Seydel JK; Wempe EG
Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):20-30. PubMed ID: 7042611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
